These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2291059)

  • 1. [Value of a percutaneous estrogen solution in stopping lactation].
    Fournier S; Foucher E; Faguer B; Pathier D
    Rev Fr Gynecol Obstet; 1990 Dec; 85(12):715-9. PubMed ID: 2291059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of CB 154 (Parlodel) in the inhibition of milk production during the immediate post-partum period].
    Monnier JC; Boulogne M; Lanciaux B; Dognin C; Denuit MP
    Lille Med; 1977 Nov; 22(9 Suppl 2):739-42. PubMed ID: 609319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of cyclofenil in the inhibition of lactation. Efficacy compared to bromocriptine].
    Cingotti M; Magnin G
    Rev Fr Gynecol Obstet; 1986; 81(6-7):369-72. PubMed ID: 3094130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a new anti-prolactin agent, Parlodel (CB 154) in the inhibition of postpartum lactation].
    Notter A; Panisset JF
    Lyon Med; 1977 Dec; 238(20):547-8. PubMed ID: 599954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medicamentous ablactation post partum. Comparative study between bromocryptin (Parlodel) and methallenoestrol (Vallestril) as well as 2 combination variants of both preparations].
    Aljinovic A; Gunti J; Pusterla E
    Gynakol Rundsch; 1976; 16(4):276-80. PubMed ID: 1037395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Postpartum myocardial infarction induced by Parlodel].
    Pop C; Metz D; Matei M; Wagner E; Tassan S; Elaerts J
    Arch Mal Coeur Vaiss; 1998 Sep; 91(9):1171-4. PubMed ID: 9805577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
    Elsener M; Ferrafiat M; de Bruyn M; Jouhet P; Robert Y; Rouge PE
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):697-701. PubMed ID: 3144727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M; Karakoç B; Gürler A
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
    Vermesh M; Fossum GT; Kletzky OA
    Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
    Baksu B; Baksu A; Göker N; Citak S
    Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of puerperal lactation with Parlodel long-acting (Parlodel LA).
    Rolland R; Nijdam W; Weyer A; Lancranjan I
    Eur J Obstet Gynecol Reprod Biol; 1986 Sep; 22(5-6):337-43. PubMed ID: 3770284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lactation.
    Llewellyn-Jones D
    Drugs; 1975; 10(2):121-9. PubMed ID: 1175477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat.
    Bonomo IT; Lisboa PC; Passos MC; Alves SB; Reis AM; de Moura EG
    J Endocrinol; 2008 Aug; 198(2):331-7. PubMed ID: 18490438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.